創傷治療用生物製剤のアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】Asia- pacific Wound Care Biologics Market : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810546)・商品コード:DBMR810546
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年8月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:アジア太平洋
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥358,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、創傷治療用生物製剤のアジア太平洋市場について調査・分析し、創傷治療用生物製剤のアジア太平洋市場動向、市場予測、セグメント別分析、創傷治療用生物製剤市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

Asia-Pacific wound care biologics market segment is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.
The key market players for Asia-Pacific wound care biologics market are listed below:
• MiMedx
• Organogenesis Inc.
• Integra LifeSciences
• ConvaTec Inc.
• Smith and Nephew
• INTEGRA LIFE SCIENCES CORPORATION
• Mölnlycke Health Care AB

The Asia-Pacific wound care biologics market is segmented into:
• Product Type
• Wound Type
• End User

On the basis of product type the Asia-Pacific wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the Asia-Pacific wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.
On the basis of wound type the Asia-Pacific wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Asia-Pacific wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.
On the basis of end user Asia-Pacific wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare. In 2018, hospitals are expected to dominate the Asia-Pacific wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.
Based on geography, the market is segmented into:
• Japan
• China
• India
• South Korea
• Australia
• Singapore
• Thailand
• Malaysia
• Indonesia
• Philippines
• Rest of Asia-Pacific
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1 Introduction 30
1.1 Objectives Of The Study 30
1.2 Market Definition 30
1.3 Overview Of Asia-Pacific Wound Care Biologics Market 30
1.4 Currency And Pricing 31
1.5 Limitation 31
1.6 Markets Covered 32
2 Market Segmentation 34
2.1 Markets Covered 34
2.2 Geographic Scope 35
2.3 Years Considered For The Study 36
2.4 Currency And Pricing 36
2.5 Research Methodology 37
2.6 Primary Interviews With Key Opinion Leaders 40
2.1 Dbmr Market Position Grid 41
2.2 Dbmr Market Challenge Matrix 42
2.3 Secondary Sources 43
2.4 Assumptions 43
3 Market Overview 44
3.1 Drivers 46
3.1.1 Increasing Cases Of Diabetic Foot Ulcers 46
3.1.2 Increasing Incidences Of Burn Cases 46
3.1.3 Rising Number Of Geriatric Population 47
3.1.4 Innovation In Wound Care Biologics 48
3.1.5 New Product Launches 50
3.2 Restrains 50
3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 50
3.2.2 Risk Of Skin Substitue Failure 51
3.3 Opportunities 52
3.3.1 3D Skin Printing 52
3.3.2 Awareness Programs 53
3.4 Challenges 54
3.4.1 Lack Of Wound Management Services 54
4 Executive Summary 55
5 Premium Insights 58
6 Asia-Pacific Wound Care Biologics Market, By Product Type 63
6.1 Overview 64
6.2 Synthetic Skin Grafts 66
6.3 Growth Factors 67
6.3.1 Platelet Derived Growth Factor (Pdgf) 70
6.3.2 Platelet Rich Plasma (Prp) 70
6.3.3 Epidermal Growth Factors (Egf) 70
6.3.4 Basic Fibroblast Growth Factors (Bfgf) 71
6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 71
6.3.6 Talactoferrin Alfa 71
6.3.7 Thrombin Peptide 72
6.3.8 Keratinocy Growth Factor (Kgf) 72
6.4 Allografts 73
6.5 Xenografts 74
7 Asia-Pacific Wound Care Biologics Market, By Wound Type 76
7.1 Overview 77
7.2 Wounds 78
7.2.1 Surgical Wound 80
7.2.1.1 Skin Surgery 81
7.2.1.1.1 Wound Closure 82
7.2.1.1.2 Skin Biopsy 82
7.2.1.1.3 Skin Flap 82
7.2.1.1.4 Skin Graft 82
7.2.1.1.5 Others 82
7.2.1.2 Cosmetic Procedure 83
7.2.1.2.1 Brest Enhancement 84
7.2.1.2.2 Facial Contouring 85
7.2.1.2.3 Facial Rejuvenation: 85
7.2.1.2.4 Body Contouring 85
7.2.1.2.5 Skin Rejuvenation 85
7.2.1.2.6 Others 86
7.2.1.3 Gynecologic Procedures 86
7.2.1.3.1 Pubovaginalis Sling 86
7.2.1.3.2 Pelvic Floor Reconstruction 87
7.2.1.3.3 Rectocele Repair Surgery 87
7.2.1.3.4 Others 87
7.2.1.4 Gastrointestinal Procedure 87
7.2.1.4.1 General Gastrointestinal Surgery 88
7.2.1.4.2 Hernia 89
7.2.1.4.3 Others 89
7.2.2 Acute Wounds 90
7.2.3 Chronic Wounds 90
7.2.4 Traumatic Wounds 91
7.3 Burns 91
7.3.1 Ulcers 92
7.3.2 Diabetic Ulcers 94
7.3.3 Pressure Ulcer 94
7.3.4 Venous Ulcer 95
7.3.5 Others 95
8 Asia-Pacific Wound Care Biologics Market, By End User 96
8.1 Overview 97
8.2 Hospitals 99
8.3 Wound Care Centers 100
8.4 Ambulatory Surgical Centers 101
8.5 Clinics 103
8.6 Community Healthcare Center 104
9 Asia-Pacific Wound Care Biologics Market: Geography 105
9.1 Asia-Pacific 105
9.1.1 China 117
9.1.2 Japan 124
9.1.3 India 131
9.1.4 South Korea 138
9.1.5 Australia 145
9.1.6 Thailand 152
9.1.7 Malaysia 159
9.1.8 Singapore 166
9.1.9 Indonesia 173
9.1.10 Philippines 180
9.1.11 Rest Of Asia-Pacific 187
10 Asia-Pacific Wound Care Biologics Market, Company Landscape 188
10.1 Company Share Analysis: Asia-Pacific 188
11 Company Profile 189
11.1 Mimedx. 189
11.1.1 Company Overview 189
11.1.2 Revenue Analysis: 189
11.1.3 Company Share Analysis: 190
11.1.4 Product Portfolio 190
11.1.5 Recent Developments 191
11.2 Organogenesis Inc 192
11.2.1 Company Overview 192
11.2.2 Geographic Presence 192
11.2.3 Company Share Analysis: 193
11.2.4 Product Portfolio 193
11.2.5 Recent Developments 194
11.3 Integra Lifesciences 195
11.3.1 Company Overview 195
11.3.2 Revenue Analysis 195
11.3.3 Company Share Analysis: 196
11.3.4 Product Portfolio 196
11.3.5 Recent Developments 197
11.4 Convatec Inc. 198
11.4.1 Company Overview 198
11.4.2 Revenue Analysis 198
11.4.3 Company Share Analysis: 199
11.4.4 Product Portfolio : 199
11.4.5 Recent Developments 199
11.5 Acell Inc. 200
11.5.1 Company Overview 200
11.5.2 Product Portfolio 200
11.5.3 Recent Developments 201
11.6 Allosource 202
11.6.1 Company Overview 202
11.6.2 Product Portfolio 202
11.6.3 Recent Developments 203
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 204
11.7.1 Company Overview 204
11.7.2 Product Portfolio 204
11.7.3 Recent Developments 204
11.8 Amnio Technology, Llc 205
11.8.1 Company Overview 205
11.8.2 Product Portfolio 205
11.8.3 Recent Developments 206
11.9 Amniox Medical, Inc. 207
11.9.1 Company Overview 207
11.9.2 Product Portfolio 207
11.9.3 Recent Developments 208
11.10 Anika Therapeutics, Inc. 209
11.10.1 Company Overview 209
11.10.2 Revenue Analysis 209
11.10.3 Product Portfolio 210
11.10.4 Recent Developments 210
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 211
11.11.1 Company Overview 211
11.11.2 Geographicpresence 211
11.11.3 Product Portfolio 212
11.11.4 Recent Developments 212
11.12 Kerecis 213
11.12.1 Company Overview 213
11.12.2 Geographical Presence 213
11.12.3 Product Portfolio 214
11.12.4 Recent Developments 214
11.13 Marine Polymer Technologies, Inc 215
11.13.1 Company Overview 215
11.13.2 Product Portfolio 215
11.13.3 Recent Developments 215
11.14 Mölnlycke Health Care Ab 216
11.14.1 Company Overview 216
11.14.2 Revenue Analysis 216
11.14.3 Product Portfolio 217
11.14.4 Recent Developments 217
11.15 Osiris Therapeutics, Inc. 218
11.15.1 Company Overview 218
11.15.2 Revenue Analysis 218
11.15.3 Product Portfolio 219
11.15.4 Recent Developments 219
11.16 Skye Biologics Inc. 220
11.16.1 Company Overview 220
11.16.2 Product Portfolio : 220
11.16.3 Recent Development: 221
11.17 Smith And Nephew 222
11.17.1 Company Overview 222
11.17.2 Revenue Analysis 222
11.17.3 Product Portfolio 223
11.17.4 Recent Developments 223
11.18 Solsys Medical. 224
11.18.1 Company Overview 224
11.18.2 Product Portfolio 225
11.18.3 Recent Developments 225
11.19 Vericel Corporation. 226
11.19.1 Company Overview 226
11.19.2 1.1.2 Revenue Analysis 226
11.19.3 Product Portfolio 227
11.19.4 Recent Developments 227
11.20 Wright Medical Group N.V 228
11.20.1 Company Overview 228
11.20.2 1.1.2 Revenue Analysis 228
11.20.3 Product Portfolio 229
11.20.4 Recent Developments 230
12 Related Reports 231

List Of Tables
Table 1 Asia-Pacific Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million) 55
Table 2 Asia-Pacific Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 56
Table 3 Asia-Pacific Growth Factors In Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million) 58
Table 4 Asia-Pacific Growth Factors In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 59
Table 5 Asia-Pacific Allografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 63
Table 6 Asia-Pacific Xenografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 65
Table 7 Asia-Pacific Wound Care Biologics Market, By Wound Type, 2015– 2025 (Usd Million) 68
Table 8 Asia-Pacific Wounds In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 69
Table 9 Asia-Pacific Wounds In Wound Care Biologics Market, By Wound Type, 2016– 2025 (Usd Million) 69
Table 10 Asia-Pacific Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million) 70
Table 11 Asia-Pacific Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million) 71
Table 12 Number Of Cosmetic Surgery, 2016 & 2017 73
Table 13 Asia-Pacific Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 74
Table 14 Asia-Pacific Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 76
Table 15 Asia-Pacific Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million) 78
Table 16 Asia-Pacific Burns In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 82
Table 17 Asia-Pacific Ulcers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 83
Table 18 Asia-Pacific Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million) 83
Table 19 Asia-Pacific Wound Care Biologics Market, By End User, 2016 – 2025 (Usd Million) 88
Table 20 Asia-Pacific Hospitals In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 89
Table 21 Asia-Pacific Wound Care Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 90
Table 22 Statistics For Ambulatory Surgical Center. U.S. 91
Table 23 Asia-Pacific Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 92
Table 24 Asia-Pacific Clinics In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 93
Table 25 Asia-Pacific Community Healthcare Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 94
Table 26 Asia-Pacific Wound Care Biologics Market, By Country, 2016-2025, (Usd Million) 100
Table 27 Asia-Pacific Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 101
Table 28 Asia-Pacific Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 101
Table 29 Asia-Pacific Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 102
Table 30 Asia-Pacific Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 102
Table 31 Europe Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 103
Table 32 Asia-Pacific Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 103
Table 33 Asia-Pacific Cosmetic Procedures In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 104
Table 34 Asia-Pacific Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104
Table 35 Asia-Pacific Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105
Table 36 Asia-Pacific Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105
Table 37 Asia-Pacific Wound Care Biologics, By End User, 2016-2025, (Usd Million) 106
Table 38 China Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 107
Table 39 China Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 108
Table 40 China Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 108
Table 41 China Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 109
Table 42 China Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 109
Table 43 China Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 110
Table 44 China Cosmetic Procedures In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 111
Table 45 China Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 111
Table 46 China Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112
Table 47 China Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112
Table 48 China Wound Care Biologics, By End User, 2016-2025, (Usd Million) 113
Table 49 Japan Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 114
Table 50 Japan Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 115
Table 51 Japan Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 115
Table 52 Japan Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 116
Table 53 Japan Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 116
Table 54 Japan Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 117
Table 55 Japan Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 118
Table 56 Japan Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 118
Table 57 Japan Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119
Table 58 Japan Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119
Table 59 Japan Wound Care Biologics, By End User, 2016-2025, (Usd Million) 120
Table 60 India Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 121
Table 61 India Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 122
Table 62 India Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 122
Table 63 India Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 123
Table 64 India Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 123
Table 65 India Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 124
Table 66 India Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 125
Table 67 India Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 125
Table 68 India Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 126
Table 69 India Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 126
Table 70 India Wound Care Biologics, By End User, 2016-2025, (Usd Million) 127
Table 71 South Korea Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 128
Table 72 South Korea Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 129
Table 73 South Korea Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 129
Table 74 South Korea Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 130
Table 75 South Korea Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 130
Table 76 South Korea Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 131
Table 77 South Korea Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 132
Table 78 South Korea Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 132
Table 79 South Korea Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 133
Table 80 South Korea Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 133
Table 81 South Korea Wound Care Biologics, By End User, 2016-2025, (Usd Million) 134
Table 82 Australia Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 135
Table 83 Australia Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 136
Table 84 Australia Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 136
Table 85 Australia Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 137
Table 86 Australia Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 137
Table 87 Australia Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 138
Table 88 Australia Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 139
Table 89 Australia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 139
Table 90 Australia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 140
Table 91 Australia Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 140
Table 92 Australia Wound Care Biologics, By End User, 2016-2025, (Usd Million) 141
Table 93 Thailand Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 142
Table 94 Thailand Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 143
Table 95 Thailand Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 143
Table 96 Thailand Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 144
Table 97 Thailand Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 144
Table 98 Thailand Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 145
Table 99 Thailand Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 146
Table 100 Thailand Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 146
Table 101 Thailand Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 147
Table 102 Thailand Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 147
Table 103 Thailand Wound Care Biologics, By End User, 2016-2025, (Usd Million) 148
Table 104 Malaysia Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 149
Table 105 Malaysia Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 150
Table 106 Malaysia Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 150
Table 107 Malaysia Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 151
Table 108 Malaysia Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 151
Table 109 Malaysia Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 152
Table 110 Malaysia Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 153
Table 111 Malaysia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 153
Table 112 Malaysia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 154
Table 113 Malaysia Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 154
Table 114 Malaysia Wound Care Biologics, By End User, 2016-2025, (Usd Million) 155
Table 115 Singapore Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 156
Table 116 Singapore Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 157
Table 117 Singapore Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 157
Table 118 Singapore Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 158
Table 119 Singapore Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 158
Table 120 Singapore Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 159
Table 121 Singapore Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 160
Table 122 Singapore Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 160
Table 123 Singapore Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 161
Table 124 Singapore Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 161
Table 125 Singapore Wound Care Biologics, By End User, 2016-2025, (Usd Million) 162
Table 126 Indonesia Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 163
Table 127 Indonesia Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 164
Table 128 Indonesia Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 164
Table 129 Indonesia Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 165
Table 130 Indonesia Surgical Wounds In Wound Care Biologics, By Wound Type, “2016-2025, (Usd Million) 165
Table 131 Indonesia Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 166
Table 132 Indonesia Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 167
Table 133 Indonesia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 167
Table 134 Philippinesgynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 168
Table 135 Indonesia Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 168
Table 136 Indonesia Wound Care Biologics, By End User, 2016-2025, (Usd Million) 169
Table 137 Philippines Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 170
Table 138 Philippines Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 171
Table 139 Philippines Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 171
Table 140 Philippines Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 172
Table 141 Philippines Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 172
Table 142 Philippines Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 173
Table 143 Philippines Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 174
Table 144 Philippines Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 174
Table 145 Philippinesgynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 175
Table 146 Philippines Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 175
Table 147 Philippineswound Care Biologics, By End User, 2016-2025, (Usd Million) 176
Table 148 Rest Of Asia-Pacific Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 177




【レポートのキーワード】

創傷治療用生物製剤

★調査レポート[創傷治療用生物製剤のアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810546)販売に関する免責事項を必ずご確認ください。
★調査レポート[創傷治療用生物製剤のアジア太平洋市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆